Pages that link to "Q33330781"

The following pages link to ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand (Q33330781):

Displaying 27 items.

• Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis (Q24600418) (← links)
• Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology (Q33605010) (← links)
• Strategy for degradomic-peptidomic analysis of human blood plasma (Q33835867) (← links)
• Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum (Q33945104) (← links)
• Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries. (Q34030497) (← links)
• Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients (Q34173955) (← links)
• Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients (Q34278535) (← links)
• Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer (Q34532251) (← links)
• Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method (Q35406116) (← links)
• Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry (Q35575887) (← links)
• Novel serum and urine markers for pediatric appendicitis (Q35680829) (← links)
• Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques (Q35773708) (← links)
• N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. (Q35874750) (← links)
• Proteomic screening of glycoproteins in human plasma for frailty biomarkers (Q36112458) (← links)
• Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis (Q36247995) (← links)
• LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma (Q36561699) (← links)
• Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma (Q36846090) (← links)
• Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo (Q38919894) (← links)
• Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response (Q39867873) (← links)
• Urinary biomarkers in pediatric appendicitis. (Q40634004) (← links)
• Autologous extracellular cytochrome c is an endogenous ligand for leucine-rich alpha2-glycoprotein and beta-type phospholipase A2 inhibitor (Q42139172) (← links)
• A highly sensitive "turn-on" fluorescent sensor for the detection of human serum proteins based on the size exclusion of the polyacrylamide gel. (Q44620950) (← links)
• Elevated plasma and vitreous levels of leucine-rich-α2-glycoprotein are associated with diabetic retinopathy progression. (Q48248160) (← links)
• LRG1 is an independent prognostic factor for endometrial carcinoma (Q51144071) (← links)
• Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker. (Q52593439) (← links)
• Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter. (Q55162688) (← links)
• Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease (Q91583935) (← links)